Related Experiment Videos
Animal models of autoimmunity
1Division of Hepatology, University of Maryland at Baltimore, 22 S. Greene Street N, Baltimore, MD 21201, USA. chowell@umaryland.edu
Clinics in Liver Disease
|October 5, 2002
Summary
Current mouse models for autoimmune hepatitis (AIH) are limited, lacking significant fibrosis or cirrhosis. Despite limitations, these models are valuable for studying AIH initiation mechanisms.
Area of Science:
- Hepatology
- Immunology
- Animal Models
Background:
- Autoimmune hepatitis (AIH) is a chronic liver disease with complex pathogenesis.
- Existing mouse models for AIH have limitations, including self-limited disease and lack of progression.
- No single model perfectly recapitulates human AIH, necessitating critical evaluation.
Purpose of the Study:
- To review the limitations of current mouse models for autoimmune hepatitis.
- To discuss the utility of these models for investigating AIH initiation.
- To highlight areas for future research and model improvement.
Main Methods:
- Review of existing literature on AIH mouse models.
- Analysis of specific models: EAIH, TGF beta-1 deficient, and IL-2 deficient models.
- Identification of common and unique limitations across models.
Main Results:
- The EAIH model shows high hepatitis in controls and inconsistent results.
- TGF beta-1 and IL-2 deficient models exhibit high mortality and short lifespans.
- All models require further characterization of T cell specificity and injury pathogenesis.
Conclusions:
- Current mouse models for AIH are imperfect but useful for hypothesis testing.
- Significant limitations exist in disease progression, fibrosis, and cirrhosis development.
- Future research should focus on refining models and detailed characterization of immune responses and injury mechanisms.